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Abstract
In recent months the COVID-19 (also known as SARS-CoV-2 and Coronavirus) pandemic has
spread throughout the world. In parallel, scholarly research regarding various aspects of the pandemic
has been extensively published. In this work, we analyse the changes in biology and medical publishing
patterns in terms of the volume of publications in both preprint servers and peer reviewed journals,
average time until the acceptance of papers to said journals, and international (co-)authorship of
papers. We study these possible changes using two approaches: a short-term analysis through which
changes during the first six months of the outbreak are examined for both COVID-19 related papers
and non-COVID-19 related papers; and a longitudinal approach through which changes are examined
in comparison to the previous four years. Our results show that the pandemic has so far had a
tremendous effect on all examined accounts of scholarly publications: A sharp increase in publication
volume has been witnessed and it can be almost entirely attributed to the pandemic; a significantly
lower mean time to acceptance for COVID-19 papers is apparent, and it has (partially) come at
the expense of non-COVID-19 papers; and a significant reduction in international collaboration for
COVID-19 papers has been identified. As the pandemic continues to spread, these changes may cause
research in non-COVID-19 biology and medical areas to be slowed down and bring about a lower rate
of international collaboration.
1 Introduction
The year 2020 began with the extremely fast spread of the COVID-19 pandemic and is expected to reach
a second peak in the upcoming months (Moore et al., 2020; World Health Organization, 2020). Countries
such as the US, India, Brazil and many others are struggling to flatten the curve. The pandemic has
impacted almost every aspect of life ranging from the economy to tourism, political affairs, the arts and
sports, thus there is global effort in searches for ways to understand and cope with it. These efforts
lay, in great part, in the hands of the scientific research community. As such, scholarly research and its
publication patterns have also been greatly effected by this current crisis.
∗avivres@biu.ac.il
†ariel.rosenfeld@biu.ac.il
1
ar
X
iv
:2
01
0.
02
59
4v
1 
 [c
s.D
L]
  6
 O
ct 
20
20
The volume of COVID-19 related publications, especially in the biological and medical fields, has
increased and has continued to sharply increase since January 2020. However, apart from this increase in
volume other changes in scholarly research are also taking place. Many journals and publication databases
now allow free access to COVID-19 related articles and data (Elesevier coronavirus Research hub, The
Lancet). Data sets of these articles such as the CORD-19 have also been curated for the creation of
analysis tools to aid in the fight against this disease.
While it is clear that scholarly publication patterns have changed dramatically due to the pandemic, it
remains unclear how these changes are manifested in a few key aspects. We focus on three such aspects
by setting the following research questions:
• How has the volume of scholarly literature in preprint servers and journals changed due to the
pandemic? Specifically, we hypothesize that the focus on COVID-19 caused a reduction in volume of
publications of other, non-COVID-19 papers in the same venues.
• How quickly are COVID-19 and non-COVID-19 papers accepted for publication? The peer review
process of journals is usually slow, but currently there is a need for fast turn around, especially
for COVID-19 papers. Specifically, we hypothesise that in order to cope with this need for fast
turn around, the time until the acceptance of COVID-19 papers has been reduced significantly from
“normal” acceptance time and that the time until the acceptance of non-COVID-19 papers has slowed
down in order to facilitate that.
• How has international (co-)authorship changed? We hypothesise that the pandemic has caused a
significant increase in international co-authorship and a wide diversity of collaboration in scholarly
research.
To address these questions we employ both a short-term analysis technique, focusing on the first 6
months of 2020 (the first six months of the outbreak), and a longitudinal analysis technique through which
we compare the publication patterns across the last five years (2016-2020). Our study employs a set of
statistical tests in order to ascertain statistically significant changes. These tests are conducted at both
the short-term and longitudinal levels. At the short-term level, these tests indicate if any statistically
significant differences exist when comparing COVID-19 papers to non-COVID-19 ones. At the longitudinal
level, these tests indicate if any statistically significant differences exist when comparing papers published
prior to the pandemic and during the pandemic. We focus on two main types of venues for research
publication: peer reviewed Journals and Preprint servers. Preprint servers are becoming widely used in
other fields of research, such as Computer Sciences and Physics, but up until the pandemic the usage of
such publication venues in the fields of Medicine and Biology was limited (Desjardins-Proulx et al., 2013;
Maslove, 2018).
Understanding changes in publication patterns during the pandemic is valuable due to their possible
implications. As the pandemic does not seem to come to a stop, these changes, for good and for bad, may
have prolonged effects that should be considered by journal editors, recruiting and promotion committees,
funding agencies and others.
This paper is organized as follows: Section 2 presents related work in scientometric analysis of pandemic
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related research. In Section 3 we describe the data and tools we use. Section 4 presents the results to the
research questions we posed. We conclude the paper with a discussion in Section 5.
2 Background and Related Work
Numerous scientometric studies have examined how publication patterns vary during or post a pandemic
(see Zhang et al. (2020) and references therein). These studies commonly focus on one or a few scientometrics
aspects such as growth of publications in various databases, research funding agencies’ countries, average
time to acceptance and international collaboration patterns. In these works, two standard techniques are
often used: short-term technique in which publication pattern changes are analysed during a pandemic
and a longitudinal technique in which the publication pattern analysis is focused on a collection of papers
related to viral pandemics, written over a long period, usually several years.
Recent studies on the COVID-19 pandemic follow these two techniques as well. Adopting the short-term
analysis technique, da Silva et al. (2020) have examined publication volumes of COVID-19 papers and
identified top journals, countries and authors. Similarly, Costa et al. (2020) performed keyword analysis
and identified most productive countries, institutions, authors and journals, and Lou et al. (2020) observed
publication types, journals and publication countries. Chahrour et al. (2020) focused on the international
distribution of COVID-19 publications compared with the number of COVID-19 cases in the respective
countries, again adopting a short-term analysis approach. Common to the above studies is the focus on
COVID-19 related publications and they do not consider the possible changes in publication patterns of
papers unrelated to the COVID-19 pandemic which are published at the same time of the pandemic. One
exception is Homolak et al. (2020) who do focus on both COVID-19 related papers and non-COVID-19
related papers in their short-term analysis.
Adopting the longitudinal approach, Kun (2020) observed the extremely short time to acceptance
for COVID-19 papers. The author focused on the first three months of 2020 for COVID-19 papers and
compared them to papers on other coronviruses. Ahmad & Batcha (2020) have taken a different approach,
focusing solely on COVID-19 papers yet examining them over the years 2011-2020. Similarly, (Mao et al.,
2020; Tao et al., 2020; Zhai et al., 2020) studied the same for the years 2000-2020 and they examined the
publications’ countries of origin, collaboration networks, authors, keywords and additional publication
characteristics. In the same vein, Kagan et al. (2020) analysed publications related to multiple nCov
viruses and compared those to influenza and additional viruses, and Zhang et al. (2020) did a comparative
bibliometric study of multiple outbreaks and performed a preliminary analysis of the COVID-19 outbreak.
Our study complements the above in three respects: 1) By providing both a short-term analysis as
well as a longitudinal one, our study gives a wider perspective in which the influence of the pandemic on
current research can be observed; 2) We focus on both COVID-19 and non-COVID-19 papers, providing
an assessment of how the effects of the pandemic differ in respect to these two types of papers; and 3)
To the best of our knowledge, we provide the most extensive scientomteric-based research on COVID-19
publications to date as we analyse the first six months of the pandemic.
Our study further compares preprint servers and peer-reviewed journals as possible dissemination
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venues for COVID-19 research output. Prior research by Krumholz et al. (2020) and Johansson et al.
(2018) have shown an increase in the usage of preprint servers in previous pandemics. Recently, evidence
was provided to support their findings in the current pandemic as well (Fraser et al., 2020; Fry et al.,
2020). While the focus of these studies was papers related to the pandemic in preprint servers, our work
extends these works by observing longitudinal changes in both COVID-19 and non-COVID-19 publications
in these venues as well as assessing the influence the pandemic had on these changes.
3 Methodology
3.1 Sources
The data for this research was obtained from four main sources:
• Elseviers’ ScienceDirect and Scopus. ScienceDirect is a full-text scientific database which is part of
SciVerse. Scopus is an abstract and citation database of peer-reviewed literature. Utilizing both
ScienceDirect and Scopus API we extracted data on COVID-19 related journal articles.
• medRxiv (pronounced "med-archive") is a free online archive and distribution server for complete but
unpublished manuscripts (preprints) in the medical, clinical, and related health sciences. The server
was founded by Cold Spring Harbor Laboratory (CSHL), a not-for-profit research and educational
institution, Yale University, and BMJ (mostly referred to as the British Medical Journal), a global
healthcare knowledge provider.
• bioRxiv (pronounced "bio-archive") is a free online archive and distribution service for unpublished
preprints in the life sciences. It is operated by CSHL.
• arXiv is an open archive for scholarly preprints in various fields. It is maintained and operated by
Cornell University.
In addition to the above described datasets we have also extracted supplementary data from PubMed
which is a web-portal of the medical database MEDLINE; and ScimagoJR - a publicly available portal
which includes journals and country scientific indicators developed from the information contained in the
Scopus database, created by SCImago research group (González-Pereira et al., 2010).
3.2 Retrieval Process
To understand the publication behaviour in the first months of the pandemic, we analysed the data which
was extracted from the sources described in Section 3.1. The search in ScienceDirect was done using the
search query "COVID-19" OR Coronavirus OR "Corona virus" OR Coronaviruses OR "2019-nCoV"
everywhere in the document. The journals with the highest numbers of COVID-19 related publications
were selected for further analysis. For each journal both COVID-19 and non-COVID-19 related papers’
data was downloaded separately. Data was downloaded for each year in our analysis (2016-2020) and split
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up by months according to the online availability date of the paper. Additional data for each paper was
extracted via its DOI from PubMed Entrez and through Scopus API. Duplicates as well as papers with
missing data were removed automatically. Records for the examined papers were analysed according to
various attributes including publicizing journal, authors, publicizing countries and numerous dates.
In order to retrieve and analyse COVID-19 data from bioRxiv, medRxiv and arXiv, we queried
the archive servers with the search query - "COVID-19" OR Coronavirus OR "Corona virus" OR
Coronaviruses OR "2019-nCoV". This query was executed separately for each of the first six months in
2020. In addition we queried the archive servers for all papers published in each of the first six months of
the years 2016-2020. The retrieved results were downloaded and automatically analysed using designated
scripts written by the authors. A subset of the results were manually tested to ensure both accuracy of
the data and the scripts. As the arXiv server is used for many fields of research and our study focused
on Biological and Medical papers, the data extraction from the arXiv server was limited only to the
“quantitative biology” field.
3.3 Analysis Approach
We analyse three main aspects of our data: 1) Publication growth that has occurred during the pandemic;
2) Changes in the time to acceptance of peer reviewed papers; and 3) Changes in authors’ countries
of affiliation and international collaborations. These three aspects are analysed and reported for both
COVID-19 papers as well as “standard” non-COVID-19 papers published during the pandemic. This
comparative approach allows us to identify the effects of the pandemic on the three examined aspects
both for pandemic-related research as well as the standard biological and medical research published
during that time. The above three aspects are further analysed for pre-pandemic papers published in
the years 2016-2019 and compared against the COVID-19 papers and non-COVID-19 papers published
in 2020. This part of the study allows us to identify the effects of the pandemic on the three examined
aspects in a longitudinal view. Some of the following analyses, especially regarding time to acceptance,
authors’ country of affiliation and international collaboration, require a large volume of publications.
Thus, for these analyses we selected a subset of biological and medical journals with the highest number
of COVID-19 paper publications. These are shown in Table 2.
4 Results
4.1 Publication Growth
Analysing the publication growth in the first six months of 2020 shows that not only a huge surge of
COVID-19 related publications is present, as one could expect, but also that these publications are
disseminated across multiple venue types. As discussed before, this work focuses on two venue types-
preprint servers and peer reviewed journals.
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Figure 1: Publication growth of COVID-19 related papers and total papers in preprint servers, compared
to the pandemic spread in the first six months of the years 2016-2020
4.1.1 Publication Growth in Preprint Severs
Figure 1 shows that preprint servers are considered a legitimate and even valuable source of dissemination
at this time. Interestingly, the publication growth was observed for both COVID-19 publications as well
as for non-COVID-19 related papers in all of the preprint servers we analysed. Furthermore, the growth
in COVID-19 publications increased in a similar fashion to the international spread of the pandemic,
although some decline was apparent in June in the medRxiv preprint server.
The sharpest increase in publications was observed in medRxiv, which was created as a preprint server
in mid-2019. While the total number of papers published in it has increased from 200 in January 2020 to
nearly 1800 in June 2020 (a factor of 9), the number of COVID-19 related papers increased from 40 in
January 2020 to 1350 in June 2020 (a factor of 34). COVID-19 papers showed an increase in percentage
from 19.5% to 75% of total papers published on the server during these months.
Focusing on the arXiv preprint server, which is well known for publications in Physics and Computer
Science, reveals that the number of publications in biology (quantitative-biology field in the arXiv, q-bio
for short) was low over the last four years with a slow, almost flat, increase. However, from January
2020 and until June 2020, the total number of publications in the q-bio field had almost doubled and the
number of COVID-19 related papers had increased by a factor of 8. The percentage of COVID-19 papers
increased from 20% in the month of February to 35% in June, of total papers published in the q-bio field
of the server in these months1.
4.1.2 Publication Growth in Journals
Turning to the analysis of peer reviewed journal publications, we observe that the growth in publication
rates is correlated with the journals’ “Scimago Journal Rank”, (SJR) (González-Pereira et al., 2010).
Specifically, in low ranking journals, which are journals in the fourth quartile of their subject area or not
in any quartile, hardly any COVID-19 papers were published. In contrast, the vast majority of COVID-19
papers were published in the highest ranked journals. Specifically, using the SJR score as a sorting criteria,
31% of the COVID-19 papers we analysed were published in top ranking journals (∼20% of the analysed
1No COVID-19 related papers were published in the arXiv q-bio field in January.
6
Table 1: COVID-19 articles published in highest ranking and lowest ranking journals. % shown is of total
of COVID-19 papers
Journal name COVID-19 papers SJR %
The Lancet 344.0 14.550 19.38
The Lancet Infectious Diseases 113.0 9.040 6.37
The Lancet Global Health 46.0 8.055 2.59
The Lancet Respiratory Medicine 57.0 7.516 3.21
Brazilian Journal of Anesthesiology 7.0 0.110 0.39
Visual Journal of Emergency Medicine 7.0 0.110 0.39
Medical Hypotheses 157.0 0.108 8.84
New Scientist 3.0 0.103 0.16
journals) with SJR ranking between 7.516 and 14.55. Only 9.8% of the COVID-19 papers were published
in bottom ranking journals (∼20% of analysed journals) with SJR ranking between 0.103 and 0.11. Table
1 shows the top ranking journals and the lowest ranking journals with the number of COVID-19 articles
they published. Excluding two low ranked journals with an exceptionally high number of COVID-19
publications, only 1.8% of the COVID-19 papers were published in bottom ranking journals (∼20% of the
analysed journals) with SJR ranking lower than 0.25.
The Pearson correlation between the total number of COVID-19 publications and the SJR of the
associated journal is moderately positive with r = 0.57, and statistically significant at p = 0.0053. We
further calculated the Pearson correlation between the percent of COVID-19 papers out of total papers in
each journal in the first six months of 2020 and the SJR score of that journal. The correlation is positive
with r = 0.177 but not statistically signficant at p = 0.43. This result could be due to the large amount of
papers published in most high ranking journals irrespective of COVID-19.
Table 2 focuses on the top COVID-19 publishing journals in which, especially in April, May and June
2020, COVID-19 papers comprised a substantial percentage of papers published in these journals. Journals
in the table are ordered according to their SJR score from 2019.
Similar to Figure 1 which presents the growth in preprint papers, Figure 2 shows the COVID-19 publi-
cation growth for journals in Table 2 as compared with publication growth over the last four years. While
we can see a large surge in the total number of publications as compared to previous years, COVID-19
publications seem to account for virtually the entire growth. Specifically, the number of non-COVID-19
related publications follows the same pattern of previous years.
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Table 2: COVID-19 related papers’ growth in Scopus journals in the first six months in 2020. Cov19 -
COVID-19 related papers, Total - total published papers in that month. % - COVID-19 out of Total in
month. Table shows subset of journals with high, medium and low ranking. This subset was selected due
to the high volume of COVID-19 papers published in each of its journals
Journal SJR
January February March April May June
Cov19 Total Cov19 Total Cov19 Total Cov19 Total Cov19 Total Cov19 Total
The Lancet
Infectious Diseases 9.040 0 38.0 6 48.0 22 66.0 32 71.0 25 69.0 28 120.0
0.00% 12.50% 33.33% 45.07% 36.23% 23.33%
The Lancet
Global Health 8.055 0 34.0 1 38.0 10 37.0 18 40.0 11 31.0 6 32.0
0.00% 2.63% 27.03% 45.00% 35.48% 18.75%
The Lancet
Respiratory Medicine 7.516 0 22.0 2 36.0 9 38.0 13 27.0 17 30.0 16 49.0
0.00% 5.56% 23.68% 48.15% 56.67% 32.65%
International Journal
of Infectious Diseases 1.437 2 53.0 6 63.0 7 42.0 28 79.0 31 82.0 28 99.0
3.77% 9.52% 16.67% 35.44% 37.80% 28.28%
Journal of
Hospital Infection 1.295 2 15.0 5 22.0 10 23.0 11 32.0 16 33.0 17 37.0
13.33% 22.73% 43.48% 34.38% 48.48% 45.95%
Travel Medicine
and Infectious Disease1.075 5 18.0 9 13.0 17 26.0 39 56.0 19 31.0 21 31.0
27.78% 69.23% 65.38% 69.64% 61.29% 67.74%
American Journal
of Infection Control 0.989 1 22.0 0 17.0 0 19.0 10 31.0 13 28.0 22 46.0
4.55% 0.00% 0.00% 32.26% 46.43% 47.83%
Journal of Infection 0.989 3 24.0 9 25.0 12 19.0 51 59.0 46 58.0 75 96.0
12.50% 36.00% 63.16% 86.44% 79.31% 78.12%
Asian Journal
of Psychiatry 0.736 0 5.0 1 53.0 3 16.0 38 82.0 18 53.0 46 96.0
0.00% 1.89% 18.75% 46.34% 33.96% 47.92%
Diabetes & Metabolic
Syndrome: Clinical... 0.124 0 19.0 0 20.0 2 10.0 13 36.0 29 59.0 36 60.0
0.00% 0.00% 20.00% 36.11% 49.15% 60.00%
Medical Hypotheses
0.108 1 46.0 1 30.0 3 43.0 33 73.0 67 103.0 52 98.0
2.17% 3.33% 6.98% 45.21% 65.05% 53.06%
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Figure 2: Publication growth of COVID-19 and non-COVID-19 related papers compared with total papers
in the examined Scopus journals in the first six months of the years 2016-2020
4.2 Time to Acceptance
Following the results reported in Section 4.1.2, we now turn to investigate how this publication growth
has affected the time to acceptance for the papers. Naturally, time to acceptance is only applicable to
journal publications and not for preprint ones. For each of the journals analysed in Table 2, we calculated
the time to acceptance in each of the six examined months for the years 2016-2020 by calculating mean
and standard deviation (STD) of the time to acceptance. The time to acceptance is defined here as the
period between the “date received” and the “date accepted” or the “date online”, whichever is earlier. Data
entries for which the “date received” or both the “date accepted” and the “date online” were missing or
corrupted were omitted from our analysis. We obviously omitted inaccurate data entries for which the
“date received” was later than (or the same as) the “date online” or the “date accepted”.
Figure 3 displays the mean time to acceptance for COVID-19 and non-COVID-19 publications in each
of the first six months in 2020 alongside the mean time to acceptance of all papers published in the same
months in 2016-2019, inclusive. The journals in the figure are ordered by their rank. Observing the mean
time to acceptance for COVID-19 papers in all journals, starting from the month of February 2020 onward,
we see it is extremely short, both when compared against non-COVID-19 papers from the same month
and onward and when compared against papers from the previous years.
We performed a series of one tailed t-tests comparing mean time to acceptance of COVID-19 papers
to non-COVID-19 papers. The test was performed for each of the months February-June of 20202 as well
as for the average time to acceptance from months January-June of 2020. Values are shown in Table 3.
As can be seen, all of these tests revealed a statistically significant difference in mean time to acceptance
with p < 0.05. In February 2020, for example, the average time to acceptance of non-COVID-19 papers
was almost 10 times longer than that of COVID-19 papers. Across the examined period, on average,
non-COVID-19 papers suffered from an average time to acceptance of 91.3 days compared to 19.3 days for
2Data for January was insufficient to perform this test.
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Table 3: Mean, STD, T-Test T statistics and p-value of time to acceptance for COVID-19 and non-
COVID-19 papers. Results in bold are statistically significant.
Months
COVID-19 non-COVID-19
t-test statistic p-value
Mean STD Mean STD
February 9.71 26.72 88.15 80.3 -12.5 1.06e-24
March 11.4 23.6 81.6 76.9 -12.7 1.35e-30
April 14.6 21.4 93.3 87.17 -15.22 1.24e-40
May 21 17.6 106.5 91.47 -15.8 2.81e-42
June 24.5 25.6 92.2 78.8 -16.66 6.36e-51
Total, first six months 19.3 23.37 91.36 81.67 -35.58 5.64e-223
Table 4: Mean, STD, T-Test T statistics and p-value of time to acceptance for each two consecutive years
in 2016-2020. Results in bold are statistically significant.
Years
First year Second year
t-test statistic p-value
Mean STD Mean STD
2016-2017 77.27 77.11 77.32 82.2 0.016 0.49
2017-2018 77.32 82.2 73.55 76.85 -1.078 0.14
2018-2019 73.55 76.85 75.79 77.47 0.72 0.23
2019-2020 75.79 77.47 65.95 75.47 -3.93 .8 4.21e-5
2019-2020 non-COVID-19 75.79 77.47 91.35 81.67 5.56 1.44e-8
COVID-19 papers (a factor of 4.7).
Additional support for the above phenomena can be seen in Table 4 as well. Taking a longitudinal
approach, we compare each pair of consecutive years as to the mean time to the acceptance of papers
from our examined journals. As can be seen in the table, until 2019, inclusive, no significant changes
were observed. For 2019 and 2020 we see that papers published in 2020 suffered from a longer time to
acceptance, both when considering the entire publication set as well as when focusing on non-COVID-19
papers alone.
Due to our previous finding that high ranked journals yield a higher number of COVID-19 papers, we
expected this to affect the time to acceptance as well. Two contradicting hypotheses can be assumed:
1) The high volume of papers submitted to high ranked journals yields a longer acceptance time; and 2)
The high volume of accepted papers to high ranked journals implies a faster review process and a shorter
acceptance time.
In order to examine these hypotheses, we calculated the Pearson correlation between the SJR score of
a journal and the mean acceptance time of COVID-19 related papers for that journal. The correlation
was found to be weakly negative, as would be expected from the second hypothesis, but not statistically
significant (r = −0.266, p = 0.43).
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Figure 3: Mean time to acceptance in selected Scopus journals for COVID-19 papers compared with
non-COVID-19 papers in the first six months of 2020 and on average over the years 2016-2019. For each
journal- Average in preceding years - magenta, January (top green and blue bar), February, March, April,
May and June (Bottom bar). Journals are ordered according to SJR score, as shown in Table 2.
The results are also depicted in Figure 4, which displays the mean time to acceptance and the Standard Error
of the Mean (SEM) averaged over all analysed journals from Table 2 in the first six months of each of the years
2016-2020. The figure also presents the mean and SEM for COVID-19 and non-COVID-19 related publications
in 2020. We first observe an apparent trend for COVID-19 publications which is first declining sharply from
January to February, mainly attributed to the relatively low number of COVID-19 papers in January and thus
the high SEM in January, and then inclining moderately from February onwards, mainly due to the increase of
COVID-19 papers. However, despite the trend, COVID-19 publications enjoy a shorter time to acceptance period
compared both to non-COVID-19 publications in 2020 and to publications in 2016-2019. As we speculated before,
non-COVID-19 publications in 2020 have “paid the price” for the shortened time to acceptance of the COVID-19
papers by exceeding the trend of previous years.
4.3 Top Publishing Countries and International Collaboration
4.3.1 Top Publishing Countries
We focus on the countries with the highest COVID-19 related publications and compare them to the top publishing
countries of non-COVID-19 papers in the first six months of 2020, as well as to the historical data from the last
four years. In Table 5 we report the comparison between COVID-19 and non-COVID-19 publications for the first
six months of 2020. A longitudinal perspective over last four years is presented in Figure 5.
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Figure 4: Mean time to acceptance for COVID-19 papers compared with non-COVID-19 and all published
papers in the first six months of 2016-2020, averaged over the number of journals in each month (journals
of Table 2). SEM is calculated and displayed separately for each month.
Table 5: Top COVID-19 and non-COVID-19 publishing countries
January February March
Cov19 Non-Cov19 Cov19 Non-Cov19 Cov19 Non-Cov19
Colombia 2 United States 64 China 16United Kingdom66 China 33 United States 60
Switzerland 2 United Kingdom56United Kingdom 8 United States 64 United States 22United Kingdom43
Canada 2 China 30 Hong Kong 4 China 32United Kingdom13 China 31
Hong Kong 2 Australia 22 United States 4 India 30 France 6 Australia 17
Spain 2 Netherlands 20 Colombia 3 Australia 25 Hong Kong 6 Germany 17
Ireland 1 Canada 18 Italy 3 Italy 24 Australia 5 Brazil 17
Nepal 1 Switzerland 17 Japan 3 Germany 23 Italy 5 Switzerland 16
Saudi Arabia 1 Germany 17 Nepal 2 Canada 20 Singapore 5 Canada 15
Nigeria 1 Japan 14 Argentina 2 Netherlands 19 Switzerland 5 Italy 14
Brazil 1 India 13 India 2 France 19 Norway 3 France 12
April May June
Cov19 Non-Cov19 Cov19 Non-ov19 Cov19 Non-Cov19
China 70 United States 63 United States 47 United States 74 United States 56 United States 96
United States 42United Kingdom40United Kingdom40 China 36 China 43 China 64
United Kingdom36 China 37 China 39United Kingdom30United Kingdom42United Kingdom58
India 34 India 25 India 33 India 28 India 41 India 33
Italy 24 Australia 20 Italy 23 Italy 19 Italy 27 Australia 32
France 13 France 18 France 16 France 19 France 15 France 29
Iran 11 Spain 18 Germany 13 Australia 16 Germany 12 Italy 23
Hong Kong 11 Switzerland 17 Iran 13 Germany 13 Japan 11 Japan 22
Norway 10 Japan 17 Hong Kong 13 Switzerland 13 Brazil 10 Spain 22
Canada 9 Iran 17 Australia 12 Sweden 12 Canada 8 Germany 20
As can be seen from both figures, while the top publishing countries have remained almost the same over the
past five years, a consistent growth in the number of papers is evident. This is consistent with our previous findings
showing the total growth of publications over the years and most significantly in 2020. It is interesting to note
that despite the fact that the same countries are top publishing countries throughout the years regardless of the
pandemic, Italy is the anomaly as it has never ranked in the top five before but during the pandemic has played a
major part in COVID-19 research, as can be seen from its ranking as 4th in COVID-19 related publications. A
similar pattern is displayed by Brazil and Hong Kong. Both are in the top 10 publishing countries for COVID-19
papers but with an average world ranking of 14 and 34 in the SJR country ranking, respectively. This can be
explained by the large outbreak of the pandemic in these three countries during the examined months.
4.3.2 International Collaboration
In this study, an international collaboration is defined as papers authored by two or more authors affiliated with
institutions in different countries. We examine two facets of international collaborations: Diversity of collaboration,
i.e., the number of countries with which each country has collaborated over a given time period. For example, a
12
Figure 5: Number of publications by top publishing countries for the Scopus selected journals. The
numbers are averaged over the first six months of each year. 2020-cov shows the average number of
COVID-19 related publications for top publishing countries in the first six months of 2020. 2020-non-cov
shows the average number of COVID-19 related publications for the top publishing countries in the first
six months of 2020.
country which has published papers with 10 other countries is more internationally collaboratively diversified than
a country who has published with 5 other countries, irrespective of the number of papers published; and “volume”
of collaboration, i.e., the number of publications which each country has published in collaboration with other
countries over a given time period. For example, a country who has published 10 papers with one other country is
more internationally productive than a country who has published 5 papers, even if each of the papers is published
with a different country.
Diversity of international collaboration. As before, we employed both a short-term analysis, comparing
COVID-19 related publications to non-COVID-19 related ones, and a longitude analysis, where the diversity in
international collaboration is measured over the past four years and compared to the year 2020.
Figure 6 displays a comparison of COVID-19 and non-COVID-19 collaborations in 2020. In order to assess the
impact of the COVID-19 pandemic on international collaborations at the time of the pandemic, we measured for
each country the number of countries it had collaborated with for COVID-19 related papers and for non-COVID-19
related papers. This was performed in each of the months February-June of 20203 separately and also for the total
first six months of 2020. For each of these periods, the mean number of collaborating countries was calculated
and a t-test was performed. The results are shown in Table 6. Our findings showed that for all periods tested,
except for the month of May, the mean number of collaborating countries in non-COVID-19 papers was found to
be statistically significantly greater than the mean number of collaborating countries for COVID-19 papers, with
p < 0.05.
Figure 7 presents a longitudinal view of international collaboration diversity. For this analysis, we counted
for each country the number of countries it collaborated with in the first six months of each year. Similar to the
trend we saw for top publishing countries, the top collaborating countries have remained almost the same over
the past five years and a consistent growth in the number of countries with which each of these top countries
3Data for January was insufficient to perform this test.
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Table 6: Mean, STD, T-Test T statistics and p-value of the number of collaborating countries for
COVID-19 and non-COVID-19 papers. Results in bold are statistically significant.
Months
COVID-19 non-COVID-19
t-test statistic p-value
Mean STD Mean STD
February 6.32 3.59 13.65 12.88 4.72 3.8e-5
March 4.41 3.68 11.89 11.24 4.96 1.6e-6
April 10.45 9.31 48.5 28.6 12.43 2.46e-24
May 12.23 10.9 12.76 10.8 0.28 0.39
June 7.41 7.15 13.1 12.18 3.47 0.0004
Total, first six months 15.39 13.97 42.07 34.04 -8.577 9.73e-16
Table 7: Mean, STD, T-Test T statistics and p-value of the number of collaborating countries for each
two consecutive years in 2016-2020. Results in bold are statistically significant.
Years
First year Second year
t-test statistic p-value
Mean STD Mean STD
2016-2017 13.16 13.49 14.5 15.43 -0.71 0.24
2017-2018 14.5 15.43 22.32 18.54 -3.63 0.0002
2018-2019 22.32 18.54 30.81 24.24 -3.2 0.0007
2019-2020 30.81 24.24 42.94 34.62 -3.49 0.0002
2019-2020 COVID-19 30.81 24.24 15.39 13.97 -6.13 -2e-9
2019-2020 non-COVID-19 30.81 24.24 42.07 34.04 3.233 0.00069
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Figure 6: Top collaborating countries for the Scopus selected journals. The Y axis shows the number of
countries collaborating with the top collaborating countries.
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Figure 7: Top collaborating countries for the Scopus selected journals. Numbers are aggregated over the
first six months of each year. 2020-cov shows an aggregated number of countries collaborating with top
collaboration countries for COVID-19 in the first six months of 2020.
collaborated is evident. To verify our observations, we performed pairwise t-tests for each two consecutive years
in our study for all countries which collaborated with at least one other country in the first six months of the
years 2016-2020. Results are shown in Table 7. The results show that for all examined periods, the number of
collaborating countries is steadily increasing. The differences are statistically significant from the 2017-2018 period
onward, p < 0.05. In addition, we ran t-tests comparing international collaboration in 2019 compared with 2020
but observed collaboration only for COVID-19 related publications and similarly for only non-COVID-19 related
publications. While both showed a statistically significant difference, the direction is reversed as the mean number
of collaborating countries for 2020 COVID-19 papers is statistically significantly smaller than that of 2019, but
the mean number of collaborating countries for 2020 non-COVID-19 papers is statistically significantly larger
than that of 2019, p < 0.05 for all accounts.
An increase in collaboration diversity over the years has been demonstrated in previous works as well (Leydesdorff
& Wagner, 2008; Wagner & Leydesdorff, 2005). The results presented here complement these findings by showing
that the year 2020 has experienced the largest increase in the number of collaborating counties. However, the
findings from the comparison of 2019 to the 2020 COVID-19 papers along with the findings when comparing
COVID-19 and non-COVID-19 collaborations (as shown in Table 6) show that collaboration in COVID-19 papers
is, surprisingly, low. Specifically, it is lower when compared to non-COVID-19 papers, lower when compared to
collaboration in the past and lower than what we would expect during a pandemic, where collaboration is of
increased significance.
Volume of international collaboration As before, we employed a short-term analysis, where the volume
of COVID-19 related collaborated publications were compared to non-COVID-19 related ones, and a longitudinal
analysis where the volume of internationally collaborated publications is measured over the past four years and
compared to the year 2020.
Figure 8 displays the countries with the highest number of papers written in international collaboration for
COVID-19 papers compared with non-COVID-19 papers in the first six months of 2020.
We start by analysing two extreme cases, papers written with no collaboration at all, and papers written
in any form of collaboration, meaning, at least two countries collaborated on the authorship of that paper. For
16
Figure 8: Top collaborating countries for the Scopus selected journals. The Y axis shows the number of
papers published by top collaborating countries.
Figure 9: Top collaborating countries for the Scopus selected journals. The Y axis shows the percentage of
papers published by top collaborating countries out of the total papers published in the same time period.
Collaboration for COVID-19 publications is compared with publications from the first six months in the
previous four years. Numbers in parentheses are the total number of papers published by this country in
collaboration with other countries.
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Table 8: Number of papers published by a single country, multiple countries, χ2 statistics and p-value for
COVID-19 and non-COVID-19 papers. Results in bold are statistically significant.
Months
COVID-19 non-COVID-19
χ2 statistic p-value
Single CountryMulti Country Single CountryMulti Country
February 18 67 187 418 2.93 0.08
March 61 85 151 281 1.9 0.16
April 188 248 185 457 22.8 1.75e-6
May 181 251 173 352 7.76 0.005
June 226 204 235 510 49.6 1.86e-12
Total, first six months 681 870 1077 2394 77.58 1.27e-18
Table 9: Number of papers published by a single country, multiple countries, χ2 statistics and p-value for
each two consecutive years in 2016-2020. Results in bold are statistically significant.
Years
First year Second year
χ2 statistic p-value
Single CountryMulti Country Single CountryMulti Country
2016-2017 582 909 616 954 0.006 0.94
2017-2018 616 954 708 1232 2.66 0.1
2018-2019 708 1232 854 1602 1.33 0.25
2019-2020 854 1602 1756 3260 0.03 0.96
2019-2020 COVID-19 854 1602 681 870 33.18 8.38e-9
2019-2020 non-COVID-19 854 1602 1077 2394 9 0.003
the following analysis we perform a χ2 test (Pearson, 1900) for comparing single country authored papers to
multi-country authored papers. The test was performed for each of the months February-June of 20204 and as a
sum over the first six months of 2020. In each time period we examined how many papers were published by a
single country (all authors from the same country) and how many were in collaboration with other countries. This
was done for COVID-19 papers and for non-COVID-19 papers. The results are shown in Table 8. Based on the χ2
statistic and p values we can conclude that for the months of April, May and June 2020 and for the total over
the six months, the type of paper (i.e., COVID-19 or non-COVID-19 related) is significantly associated with the
authorship by a single country or multiple countries. Specifically, authorship by a single country is indicative of
COVID-19 related papers while co-authorship by multiple countries is indicative of non-COVID-19 related papers.
Additional χ2 tests were performed to analyse if the pandemic affected the number of papers internationally
co-authored compared to previous years. In this test we measured the mean number of papers authored by single
countries and the mean number of papers authored by multiple countries in the first six months of each two
consecutive years in our study, comparing 2016-2017, 2017-2018, 2018-2019, 2019-2020. This can be seen in Table
9. Our results for the longitudinal χ2 test are statistically significant at p < 0.05 in two specific cases: When
comparing international co-authorship for 2019 papers to 2020 COVID-19 papers; and when comparing authorship
for 2019 papers to 2020 non-COVID-19 papers.
4As before, data for January was insufficient to perform this test.
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Table 10: Mean, STD, T-Test T statistics and p-value of the number of internationally collaborated
papers for COVID-19 and non-COVID-19 papers. Results in bold are statistically significant.
Months
COVID-19 non-COVID-19
t-test statistic p-value
Mean STD Mean STD
February 1.55 1.02 5.16 7.76 4.08 5e-5
March 2.5 2.76 4 5.9 1.76 0.04
April 3.75 5.34 4.35 5.36 0.7 0.24
May 4.18 5.67 3.96 6.3 0.22 0.4
June 3.46 4.91 5.93 9.53 2.03 0.022
Total, first six months 8.45 15.64 15.55 32.9 -2.3 0.011
Table 11: Mean, STD, T-Test T statistics and p-value of the number of collaborating countries for each
two consecutive years in 2016-2020. Results in bold are statistically significant.
Years
First year Second year
t-test statistic p-value
Mean STD Mean STD
2016-2017 7.77 15.06 7.88 17.55 -0.05 0.48
2017-2018 7.88 17.55 9.41 20.16 -0.63 0.26
2018-2019 9.41 20.16 11.87 24.57 -0.89 0.19
2019-2020 11.87 24.57 20.5 45.13 -2.07 0.019
2019-2020 COVID-19 11.87 24.57 8.45 15.64 -1.3 0.09
2019-2020 non-COVID-19 11.87 24.57 15.55 32.93 -1.08 0.14
Analysing both the results from the short-term and the longitudinal χ2 test, our findings indicate that for
COVID-19 related papers, the volume of papers co-authored by multiple countries is large, both in comparison to
non-COVID-19 related papers and to previous years’ international collaboration behaviour.
In order to better understand the previous findings, we performed a series of short-term analysis t-tests and a
similar series of long-term analysis t-tests. In the short-term analysis we measured, for every country, the number
of papers written in international collaboration. This was performed in each of the months February-June of 20205
and for the total first six months of 2020 for COVID-19 related papers and for non-COVID-19 related ones. The
results are displayed in Table 10 and show that for the examined periods of February, March and June and the
total first six months of 2020, the mean number of COVID-19 collaboration papers is statistically significantly
smaller than for non-COVID-19, with p < 0.05.
In the longitudinal analysis we measured, for every country, the number of papers written in international
collaboration. This was performed by summing, for each country, the number of internationally collaborated papers
over the first six months in each of the years 2016-2020. Figure 9 displays the countries with the highest number of
papers written in international collaboration over the last five years. We can observe two interesting collaboration
patterns here. The first is that the number of papers written in collaboration has continually increased for the
top collaborating countries. This is consistent with our findings of growth in total publications over the past five
5Data for January was insufficient to perform this test.
19
years as can be seen in Figure 2. The second finding that can be observed is that although the US and UK have
remained the top two collaborating countries, when observing collaboration for COVID-19 publications, China is
extremely collaborative and Italy is in the top 5 collaborating countries. This can be explained by the pandemic
originating in China and its wide spread in Italy.
We performed pairwise t-tests for each two consecutive years in our study, comparing 2016-2017, 2017-2018,
2018-2019, 2019-2020 for all internationally collaborated papers published in the first six months of these years.
From Table 11 we can observe that a statistically significant difference exists only for the period 2019-2020. The
mean number of internationally collaborated papers in 2019 is statistically significantly smaller than the mean
number of internationally collaborated papers in 2020, with p < 0.05. However, this difference is not statistically
significant when comparing 2019 collaborated papers separately against 2020 COVID-19 papers and against 2020
non-COVID-19 papers. These findings indicate that when international collaboration is measured by the volume of
collaborated papers, the COVID-19 pandemic does not seem to affect the increase in international collaboration.
5 Conclusion and Discussion
In this study we have analysed how the COVID-19 pandemic effected the publication patterns in biological and
medical literature. We employed two types of analyses to address each of our research questions - short-term
analysis and a longitudinal analysis of preprint servers and peer reviewed journals.
Our analysis showed a significant increase in published papers both in peer reviewed journals and in preprint
servers compared to previous years. The new MedRxiv preprint server especially stands out with an exceptionally
large increase in publications and we expect this preprint server to continue this pattern post-pandemic. Notably,
while the increase in publication in preprint servers has occurred for both COVID-19 and non-COVID-19 related
papers, this is not the case for the journals we have analysed. In these journals virtually the entire growth was due
to COVID-19 papers while, on average, the volume of non-COVID-19 papers has remained similar to previous
years. Our results also showed that high ranked journals publish more COVID-19 papers than low ranked journals.
It is further apparent that journals had responded quickly to the pandemic by lowering the time to acceptance for
COVID-19 papers. Unfortunately, this has come at a cost for non-COVID-19 papers, whose time to acceptance
was longer than that was observed in previous years (and obviously longer than that of COVID-19 papers).
Taken jointly, the non-increasing volume and longer time to acceptance of non-COVID-19 papers may lead to
a significant slow down in non-COVID-19 related research, at the very least in journal publications. While such
research may not be “urgent”, it is, presumably, of no less importance than the current crisis. On the other hand,
we do observe an increase in the use of preprint servers irrespective of COVID-19 publications. This may indicate
that the community is recognizing the above phenomena and adjusting their publication behaviour accordingly.
Turning our focus to the countries authoring these papers, we observed the top publishing countries and
international collaboration patterns. We observed that while the US and UK have remained the top publishing
and collaborating countries, Italy, Brazil and Hong Kong have produced a significant amount of COVID-19 related
papers as well, disproportional to their lower ranking in non-COVID-19 papers today and in the last four years.
This can be explained by the major impact this pandemic has had on these countries. Our results further showed
consistent growth over the past five years in international collaboration when examining both collaboration diversity
and volume. However, contrary to our original hypothesis, international collaboration diversity in COVID-19
papers was lower than in non-COVID-19 papers and lower than the past four years. We observed that most
COVID-19 papers were authored by a single country or only a very few countries. This can be explained by
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the complexity of conducting international studies during the pandemic. However, this may also suggest that
countries are doing a significant amount of COVID-19 research nationally and knowledge is officially shared only
after the research has been published. Although the number of countries whom a single country has collaborated
in COVID-19 related papers was lower than expected, the number of such papers written in collaboration had
increased compared to non-COVID-19 papers and compared to previous years.
We recognize that the current study is limited by the amount, quality and diversity of the data used. While
this work is, to the best of our knowledge, the most extensive one on all three accounts when discussing scholarly
publications during the COVID-19 outbreak, a larger analysis may reveal additional or other trends, which were
not captured here. We plan to extend this work further to include the long-term effects of this pandemic on
scholarly research, in biological and medical literature and in other fields as well. Such research would complement
this work by analysing (hopefully) post-pandemic changes in citation patterns and the usage of preprint servers.
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